Regulation of food intake, energy balance, and body fat mass: Implications for the pathogenesis and treatment of obesity

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 3, 2012, Pages 745-755

  Guyenet, Stephan J ^a   Schwartz, Michael W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; AMFEBUTAMONE; AMYLIN; APOLIPOPROTEIN A4; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CHOLECYSTOKININ; DOPAMINE; ENTEROSTATIN; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LEPTIN; LEPTIN RECEPTOR; NALTREXONE; NEUROPEPTIDE Y; OXYNTOMODULIN; PANCREAS POLYPEPTIDE; PEPTIDE YY [3-36]; PROOPIOMELANOCORTIN; PROTEIN KINASE C THETA; PROTEIN TYROSINE PHOSPHATASE 1B; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNINDEXED DRUG;

BODY FAT; BRAIN NERVE CELL; CALORIC INTAKE; DIET RESTRICTION; ENERGY BALANCE; ENERGY EXPENDITURE; ENERGY METABOLISM; EPIDEMIC; FOOD INTAKE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HOMEOSTASIS; HORMONE RELEASE; HORMONE RESISTANCE; HUMAN; HYPOTHALAMUS; INFLAMMATION; LIPID STORAGE; NONHUMAN; OBESITY; PALATABILITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; REWARD; ROUX Y ANASTOMOSIS; SIGNAL TRANSDUCTION; SOLITARY TRACT NUCLEUS; STOMACH BYPASS; THERAPY EFFECT; UNITED STATES; ADIPOSE TISSUE; BODY MASS; EATING; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPOSE TISSUE; BODY MASS INDEX; EATING; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; OBESITY;

EID: 84858029073     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2525     Document Type: Review

References (133)

1. Omran AR 1971 The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 49: 509-538
2. Lee JM, Pilli S, Gebremariam A, Keirns CC, Davis MM, Vijan S, Freed GL, Herman WH, Gurney JG 2010 Getting heavier, younger: trajectories of obesity over the life course. Int J Obes (Lond) 34: 614-623
3. Flegal KM, Graubard BI, Williamson DF, Gail MH 2007 Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298:2028-2037 (Pubitemid 350074800)
4. Duffey KJ, Popkin BM 2011 Energy density, portion size, and eating occasions: contributions to increased energy intake in the United States, 1977-2006. PLoS Med 8:e1001050
5. Swinburn BA, Sacks G, Lo SK, Westerterp KR, Rush EC, Rosenbaum M, Luke A, Schoeller DA, DeLany JP, Butte NF, Ravussin E 2009 Estimating the changes in energy flux that characterize the rise in obesity prevalence. Am J Clin Nutr 89:1723-1728
6. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS 2001Apreprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719 (Pubitemid 33641587)
7. Woods SC, Seeley RJ, Porte Jr D, Schwartz MW 1998 Signals that regulate food intake and energy homeostasis. Science 280:1378-1383 (Pubitemid 28264819)
8. Mayer J 1953 Glucostatic mechanism of regulation of food intake. N Engl J Med 249:13-16
9. Grossman SP 1986 The role of glucose, insulin and glucagon in the regulation of food intake and body weight. Neurosci Biobehav Rev 10:295-315 (Pubitemid 16006107)
10. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Blüher M, Stumvoll M, Stampfer MJ 2008 Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359:229-241 (Pubitemid 352008438)
11. Davis JD, Smith GP 1990 Learning to sham feed: behavioral adjustments to loss of physiological postingestional stimuli. Am J Physiol 259:R1228-R1235
12. Cummings DE, Overduin J 2007 Gastrointestinal regulation of food intake. J Clin Invest 117:13-23 (Pubitemid 46048445)
13. Ritter RC 2004 Gastrointestinal mechanisms of satiation for food. Physiol Behav 81:249-273 (Pubitemid 38678643)
14. Katsuura G, Asakawa A, Inui A 2002 Roles of pancreatic poly-peptide in regulation of food intake. Peptides 23:323-329 (Pubitemid 34127969)
15. Okada S, York DA, Bray GA, Erlanson-Albertsson C 1991 Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduces fat intake. Physiol Behav 49:1185-1189
16. Lutz TA, Del Prete E, Scharrer E 1994 Reduction of food intake in rats by intraperitoneal injection of low doses of amylin. Physiol Behav 55:891-895 (Pubitemid 24133805)
17. Chapman I, Parker B, Doran S, Feinle-Bisset C, Wishart J, Lush CW, Chen K, Lacerte C, Burns C, McKay R, Weyer C, Horowitz M 2007 Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects. Obesity (Silver Spring) 15:1179-1186 (Pubitemid 46932473)
18. Geary N, Smith GP 1982 Pancreatic glucagon and postprandial satiety in the rat. Physiol Behav 28:313-322 (Pubitemid 12110684)
19. Gibbs J, Young RC, Smith GP 1973 Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 245:323-325
20. Kissileff HR, Pi-Sunyer FX, Thornton J, Smith GP 1981 C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr 34:154-160 (Pubitemid 11186304)
21. Moran TH, Ameglio PJ, Schwartz GJ, McHugh PR 1992 Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am J Physiol 262:R46-R50
22. Williams DL, Baskin DG, Schwartz MW 2009 Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety. Endocrinology 150:1680-1687
23. Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, Liu R, Moncrieffe M, Thabet K, Cox HJ, Yancopoulos GD, Wiegand SJ, Sleeman MW 2004 Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 101:8227-8232 (Pubitemid 38698082)
24. Grill HJ, Norgren R 1978 Chronically decerebrate rats demonstrate satiation but not bait shyness. Science 201:267-269 (Pubitemid 8396753)
25. Grill HJ, Smith GP 1988 Cholecystokinin decreases sucrose intake in chronic decerebrate rats. Am J Physiol 254:R853-R856
26. Kaplan JM, Seeley RJ, Grill HJ 1993 Daily caloric intake in intact and chronic decerebrate rats. Behav Neurosci 107:876-881 (Pubitemid 23339180)
27. Morton GJ, Blevins JE, Williams DL, Niswender KD, Gelling RW, Rhodes CJ, Baskin DG, Schwartz MW 2005 Leptin action in the forebrain regulates the hindbrain response to satiety signals. J Clin Invest 115:703-710 (Pubitemid 40322245)
28. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW 2006 Central nervous system control of food intake and body weight. Nature 443:289-295 (Pubitemid 44435142)
29. Cohen P, Zhao C, Cai X, Montez JM, Rohani SC, Feinstein P, Mombaerts P, Friedman JM 2001 Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 108:1113-1121 (Pubitemid 32995369)
30. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432 (Pubitemid 24365442)
31. Chin-Chance C, Polonsky KS, Schoeller DA 2000 Twenty-four-hour leptin levels respond to cumulative short-term energy imbalance and predict subsequent intake. J Clin Endocrinol Metab 85: 2685-2691 (Pubitemid 32269136)
32. Figlewicz DP, Sipols AJ 2010 Energy regulatory signals and food reward. Pharmacol Biochem Behav 97:15-24
33. Butler AA, Marks DL, Fan W, Kuhn CM, Bartolome M, Cone RD 2001 Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat Neurosci 4:605-611 (Pubitemid 32507374)
34. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Grüters A 1998 Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157 (Pubitemid 28248796)
35. Aponte Y, Atasoy D, Sternson SM 2011 AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat Neurosci 14:351-355
36. Tong Q, Ye CP, Jones JE, Elmquist JK, Lowell BB 2008 Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat Neurosci 11:998-1000
37. Wu Q, Boyle MP, Palmiter RD 2009 Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell 137:1225-1234
38. 2011 Economic Research Service. U.S. Department of Agriculture. http://www.ers.usda.gov/Briefing/CPIFoodAndExpenditures/Data/ Expenditures-tables/
39. Sclafani A 2004 Oral and postoral determinants of food reward. Physiol Behav 81:773-779 (Pubitemid 38845045)
40. Booth DA, Mather P, Fuller J 1982 Starch content of ordinary foods associatively conditions human appetite and satiation, indexed by intake and eating pleasantness of starch-paired flavours. Appetite 3:163-184 (Pubitemid 12024911)
41. Johnson SL, McPhee L, Birch LL 1991 Conditioned preferences: young children prefer flavors associated with high dietary fat. Physiol Behav 50:1245-1251
42. Lucas F, Ackroff K, Sclafani A 1989 Dietary fat-induced hyperphagia in rats as a function of fat type and physical form. Physiol Behav 45:937-946 (Pubitemid 19158281)
43. Morris MJ, Na ES, Johnson AK 2008 Salt craving: the psychobiology of pathogenic sodium intake. Physiol Behav 94:709-721 (Pubitemid 351847629)
44. Ramirez I 1991 High-fat diets stimulate transient hyperphagia whereas wet diets stimulate prolonged hyperphagia in Fischer rats. Physiol Behav 49:1223-1228
45. Ramirez I, Friedman MI 1990 Dietary hyperphagia in rats: role of fat, carbohydrate, energy content. Physiol Behav 47:1157-1163 (Pubitemid 20224217)
46. Sclafani A 1987 Carbohydrate-induced hyperphagia and obesity in the rat: effects of saccharide type, form, taste. Neurosci Biobehav Rev 11:155-162
47. Yeomans MR, Gould NJ, Mobini S, Prescott J 2008 Acquired flavor acceptance and intake facilitated by monosodium glutamate in humans. Physiol Behav 93:958-966
48. Sørensen LB, Møller P, Flint A, Martens M, Raben A 2003 Effect of sensory perception of foods on appetite and food intake: a review of studies on humans. Int J Obes Relat Metab Disord 27:1152-1166 (Pubitemid 37281663)
49. Sclafani A, Springer D 1976 Dietary obesity in adult rats: similarities to hypothalamic and human obesity syndromes. Physiol Behav 17:461-471
50. Sampey BP, Vanhoose AM, Winfield HM, Freemerman AJ, Muehlbauer MJ, Fueger PT, Newgard CB, Makowski L 2011 Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity (Silver Spring) 19:1109-1117
51. Cabanac M, Johnson KG 1983 Analysis of a conflict between palatability and cold exposure in rats. Physiol Behav 31:249-253 (Pubitemid 13048043)
52. Oswald KD, Murdaugh DL, King VL, Boggiano MM 2011 Motivation for palatable food despite consequences in an animal model of binge eating. Int J Eat Disord 44:203-211
53. Fulton S, Woodside B, Shizgal P 2000 Modulation of brain reward circuitry by leptin. Science 287:125-128 (Pubitemid 30033234)
54. Hoebel BG, Teitelbaum P 1962 Hypothalamic control of feeding and self-stimulation. Science 135:375-377
55. Powley TL, Keesey RE 1970 Relationship of body weight to the lateral hypothalamic feeding syndrome. J Comp Physiol Psychol 70:25-36
56. Ackroff K, Yiin YM, Sclafani A 2010 Post-oral infusion sites that support glucose-conditioned flavor preferences in rats. Physiol Behav 99:402-411
57. Berthoud HR 2004 Mind versus metabolism in the control of food intake and energy balance. Physiol Behav 81:781-793
58. Kenny PJ 2011 Reward mechanisms in obesity: new insights and future directions. Neuron 69:664-679
59. Berridge KC 1996 Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 20:1-25 (Pubitemid 126682107)
60. Olszewski PK, Levine AS 2007 Central opioids and consumption of sweet tastants: when reward outweighs homeostasis. Physiol Behav 91:506-512 (Pubitemid 47247783)
61. Giraudo SQ, Grace MK, Welch CC, Billington CJ, Levine AS 1993 Naloxone's anorectic effect is dependent upon the relative palatability of food. Pharmacol Biochem Behav 46:917-921
62. Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E 2010 Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 376:595-605
63. Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA 2001 Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry 58:322-328 (Pubitemid 32299527)
64. Tsou K, Brown S, Sañudo-Peña MC, Mackie K, Walker JM 1998 Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411 (Pubitemid 28062631)
65. Foltin RW, Fischman MW, Byrne MF 1988 Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite 11:1-14
66. Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A 2007 Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370:1706-1713 (Pubitemid 350100788)
67. Gessa GL, Orrù A, Lai P, Maccioni P, Lecca R, Lobina C, Carai MA, Colombo G 2006 Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats. Psychopharmacology (Berl) 185:248-254 (Pubitemid 43363621)
68. Pang Z, Wu NN, Zhao W, Chain DC, Schaffer E, Zhang X, Yamdagni P, Palejwala VA, Fan C, Favara SG, Dressler HM, Economides KD, Weinstock D, Cavallo JS, Naimi S, Galzin AM, Guillot E, Pruniaux MP, Tocci MJ, Polites HG 2011 The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice. Obesity (Silver Spring) 19: 1923-1934
69. Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrié P 2004 CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 28:640-648 (Pubitemid 38491158)
70. Xie S, Furjanic MA, Ferrara JJ, McAndrew NR, Ardino EL, Ngondara A, Bernstein Y, Thomas KJ, Kim E, Walker JM, Nagar S, Ward SJ, Raffa RB 2007 The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism-or inverse agonism-as potential obesity treatment and other therapeutic use. J Clin Pharm Ther 32:209-231 (Pubitemid 46699514)
71. Keys A 1946 Human starvation and its consequences. J Am Diet Assoc 22:582-587
72. Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S, Gallagher D, Mayer L, Murphy E, Leibel RL 2005 Low-dose leptin reverses skeletal muscle, autonomic, neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest 115:3579-3586 (Pubitemid 43121846)
73. Leibel RL 2002 The role of leptin in the control of body weight. Nutr Rev 60:S15-S19; discussion S68-84, 85-87
74. Flier JS 1998 Clinical review 94: what's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab 83:1407-1413 (Pubitemid 28500994)
75. Diaz EO, Prentice AM, Goldberg GR, Murgatroyd PR, Coward WA 1992 Metabolic response to experimental overfeeding in lean and overweight healthy volunteers. Am J Clin Nutr 56:641-655
76. Pasquet P, Apfelbaum M 1994 Recovery of initial body weight and composition after long-term massive overfeeding in men.AmJ Clin Nutr 60:861-863 (Pubitemid 24377266)
77. Roberts SB, Young VR, Fuss P, Fiatarone MA, Richard B, Rasmussen H, Wagner D, Joseph L, Holehouse E, Evans WJ 1990 Energy expenditure and subsequent nutrient intakes in overfed young men. Am J Physiol 259:R461-R469 (Pubitemid 20307566)
78. Sims EA, Danforth Jr E, Horton ES, Bray GA, Glennon JA, Salans LB 1973 Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 29:457-496
79. Tremblay A, Després JP, Thériault G, Fournier G, Bouchard C 1992 Overfeeding and energy expenditure in humans. Am J Clin Nutr 56:857-862
80. Cohn C, Joseph D 1962 Influence of body weight and body fat on appetite of "normal" lean and obese rats. Yale J Biol Med 34:598-607
81. Guo J, Jou W, Gavrilova O, Hall KD 2009 Persistent diet-induced obesity in male C57BL/6 mice resulting from temporary obesigenic diets. PLoS One 4:e5370
82. Shi H, Akunuru S, Bierman JC, Hodge KM, Mitchell MC, Foster MT, Seeley RJ, Reizes O 2009 Diet-induced obese mice are leptin insufficient after weight reduction. Obesity (Silver Spring) 17: 1702-1709
83. White CL, Purpera MN, Ballard K, Morrison CD 2010 Decreased food intake following overfeeding involves leptin-dependent and leptin-independent mechanisms. Physiol Behav 100:408-416
84. Stratford TR, Kelley AE 1999 Evidence of a functional relationship between the nucleus accumbens shell and lateral hypothalamus subserving the control of feeding behavior. J Neurosci 19:11040-11048 (Pubitemid 30235747)
85. Barone FC, Wayner MJ, Tsai WH, Zarco de Coronado I 1981 Effects of ventral tegmental area stimulation and microiontophoretic application of dopamine and norepinephrine on hypothalamic neurons. Brain Res Bull 7:181-193 (Pubitemid 12225376)
86. Cincotta AH, Meier AH 1989 Reductions of body fat stores and total plasma cholesterol and triglyceride concentrations in several species by bromocriptine treatment. Life Sci 45:2247-2254 (Pubitemid 20003070)
87. Cincotta AH, Meier AH 1996 Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects. Diabetes Care 19:667-670 (Pubitemid 26182986)
88. Jones B, Basson BR, Walker DJ, Crawford AM, Kinon BJ 2001 Weight change and atypical antipsychotic treatment in patients with schizophrenia. J Clin Psychiatry 62(Suppl 2):41-44 (Pubitemid 32154141)
89. Leibowitz SF, Rossakis C 1979 Mapping study of brain dopamine-and epinephrine-sensitive sites which cause feeding suppression in the rat. Brain Res 172:101-113 (Pubitemid 10200582)
90. Spitz MR, Detry MA, Pillow P, Hu Y, Amos CI, Hong WK, Wu X 2000 Variant alleles of the D2 dopamine receptor gene and obesity. Nutr Res 20:371-380 (Pubitemid 30183203)
91. Stice E, Spoor S, Bohon C, Small DM 2008 Relation between obesity and blunted striatal response to food is moderated by TaqIAA1 allele. Science 322:449-452
92. Stice E, Spoor S, Bohon C, Veldhuizen MG, Small DM 2008 Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. J Abnorm Psychol 117:924-935
93. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS 2001 Brain dopamine and obesity. Lancet 357:354-357 (Pubitemid 32128542)
94. Stice E, Spoor S, Ng J, Zald DH 2009 Relation of obesity to con-summatory and anticipatory food reward. Physiol Behav 97:551-560
95. Cabanac M, Rabe EF 1976 Influence of a monotonous food on body weight regulation in humans. Physiol Behav 17:675-678 (Pubitemid 8004081)
96. Hashim SA, Van Itallie TB 1965 Studies in normal and obese subjects with a monitored food dispensing device. Ann NY Acad Sci 131:654-661
97. Colantuoni C, Schwenker J, McCarthy J, Rada P, Ladenheim B, Cadet JL, Schwartz GJ, Moran TH, Hoebel BG 2001 Excessive sugar intake alters binding to dopamine and μ-opioid receptors in the brain. Neuroreport 12:3549-3552 (Pubitemid 33065496)
98. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K 2004 Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724-1737 (Pubitemid 39346675)
99. Chikunguwo S, Brethauer S, Nirujogi V, Pitt T, Udomsawaengsup S, Chand B, Schauer P 2007 Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis 3:631-635; discussion 635-636
100. Moulin de Moraes CM, Mancini MC, de Melo ME, Figueiredo DA, Villares SM, Rascovski A, Zilberstein B, Halpern A 2005 Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass. Obes Surg 15:1287-1291 (Pubitemid 41565128)
101. Shin AC, Berthoud HR 2011 Food reward functions as affected by obesity and bariatric surgery. Int J Obes (Lond) 35(Suppl 3):S40-S44
102. Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IM, Greve JW 2010 A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 251:236-243
103. Ochner CN, Gibson C, Shanik M, Goel V, Geliebter A 2011 Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes Lond 35:153-166
104. Pérez C, Sclafani A 1991 Cholecystokinin conditions flavor preferences in rats. Am J Physiol 260:R179-R185
105. Farooqi S, O'Rahilly S 2006 Genetics of obesity in humans. Endocr Rev 27:710-718 (Pubitemid 44936054)
106. Farooqi IS, O'Rahilly S 2007 Genetic factors in human obesity. Obes Rev 8(Suppl 1): 37-40
107. O'Rahilly S 2009 Human genetics illuminates the paths to metabolic disease. Nature 462:307-314
108. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM, Berndt SI, Elliott AL, Jackson AU, Lamina C, Lettre G, Lim N, Lyon HN, McCarroll SA, Papadakis K, Qi L, Randall JC, Roccasecca RM, Sanna S, Scheet P, Weedon MN, Wheeler E, Zhao JH, Jacobs LC, Prokopenko I, Soranzo N, Tanaka T, Timpson NJ, Almgren P, Bennett A, Bergman RN, Bingham SA, Bonnycastle LL, Brown M, Burtt NP, Chines P, et al. 2009 Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 41:25-34
109. Li S, Zhao JH, Luan J, Luben RN, Rodwell SA, Khaw KT, Ong KK, Wareham NJ, Loos RJ 2010 Cumulative effects and predictive value of common obesity-susceptibility variants identified by genome- wide association studies. Am J Clin Nutr 91:184-190
110. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, Allen HL, Lindgren CM, Luan J, Mägi R, Randall JC, Vedantam S, Winkler TW, Qi L, Workalemahu T, Heid IM, Steinthorsdottir V, Stringham HM, Weedon MN, Wheeler E, Wood AR, Ferreira T, Weyant RJ, Segrè AV, Estrada K, Liang L, Nemesh J, Park JH, Gustafsson S, Kilpeläinen TO, Yang J, Bouatia- Naji N, Esko T, Feitosa MF, Kutalik Z, Mangino M, Raychaudhuri S, Scherag A, Smith AV, Welch R, Zhao JH, Aben KK, Absher DM, et al. 2010 Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42:937-948
111. Taylor PD, Poston L 2007 Developmental programming of obesity in mammals. Exp Physiol 92:287-298 (Pubitemid 46376323)
112. Smith J, Cianflone K, Biron S, Hould FS, Lebel S, Marceau S, Lescelleur O, Biertho L, Simard S, Kral JG, Marceau P 2009 Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. J Clin Endocrinol Metab 94:4275-4283
113. Rokholm B, Silventoinen K, Ängquist L, Skytthe A, Kyvik KO, Sørensen TI 2011 Increased genetic variance of BMI with a higher prevalence of obesity. PLoS One 6:e20816
114. Drewnowski A, Darmon N 2005 The economics of obesity: dietary energy density and energy cost. Am J Clin Nutr 82:265S-273S
115. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161
116. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295 (Pubitemid 26033933)
117. Enriori PJ, Evans AE, Sinnayah P, Jobst EE, Tonelli-Lemos L, Billes SK, Glavas MM, Grayson BE, Perello M, Nillni EA, Grove KL, Cowley MA 2007 Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab 5:181-194
118. Münzberg H, Flier JS, Bjørbaek C 2004 Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145:4880-4889 (Pubitemid 39551104)
119. Shi H, Sorrell JE, Clegg DJ, Woods SC, Seeley RJ 2010 The roles of leptin receptors on POMC neurons in the regulation of sex-specific energy homeostasis. Physiol Behav 100:165-172
120. van de Wall E, Leshan R, Xu AW, Balthasar N, Coppari R, Liu SM, Jo YH, MacKenzie RG, Allison DB, Dun NJ, Elmquist J, Lowell BB, Barsh GS, de Luca C, Myers Jr MG, Schwartz GJ, Chua Jr SC 2008 Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion. Endocrinology 149:1773-1785 (Pubitemid 351468315)
121. Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG, Kahn BB 2006 Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med 12:917-924 (Pubitemid 44175143)
122. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D 2008 Hypothalamic IKK β/NF-κB and ER stress link overnutrition to energy imbalance and obesity. Cell 135:61-73
123. Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H, Torisu T, Chien KR, Yasukawa H, Yoshimura A 2004 Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 10:739-743 (Pubitemid 38937640)
124. Picardi PK, Calegari VC, Prada Pde O, Moraes JC, Araújo E, Marcondes MC, Ueno M, Carvalheira JB, Velloso LA, Saad MJ 2008 Reduction of hypothalamic protein tyrosine phosphatase improves insulin and leptin resistance in diet-induced obese rats. Endocrinology 149:3870-3880
125. Kleinridders A, Schenten D, Könner AC, Belgardt BF, Mauer J, Okamura T, Wunderlich FT, Medzhitov R, Brüning JC 2009 MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab 10:249-259
126. De Souza CT, Araujo EP, Bordin S, Ashimine R, Zollner RL, Boschero AC, Saad MJ, Velloso LA 2005 Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146:4192-4199 (Pubitemid 41324012)
127. Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, Stanley EG, Robb L, Greenhalgh CJ, Förster I, Clausen BE, Nicola NA, Metcalf D, Hilton DJ, Roberts AW, Alexander WS 2003 SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4:540-545 (Pubitemid 36701336)
128. Zabolotny JM, Kim YB, Welsh LA, Kershaw EE, Neel BG, Kahn BB 2008 Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem 283:14230-14241
129. Benoit SC, Kemp CJ, Elias CF, Abplanalp W, Herman JP, Migrenne S, Lefevre AL, Cruciani-Guglielmacci C, Magnan C, Yu F, Niswender K, Irani BG, Holland WL, Clegg DJ 2009 Palmitic acid mediates hypothalamic insulin resistance by altering PKC-θ subcellular localization in rodents. J Clin Invest 119:2577-2589
130. Posey KA, Clegg DJ, Printz RL, Byun J, Morton GJ, Vivekanandan- Giri A, Pennathur S, Baskin DG, Heinecke JW, Woods SC, Schwartz MW, Niswender KD 2009 Hypothalamic proinflammatory lipid accumulation, inflammation, insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab 296:E1003-E1012
131. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI 2002 Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)- associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230-50236 (Pubitemid 36042170)
132. Thaler JP, Yi C, Schur EA, Guyenet SJ, Hwang BH, Dietrich MO, Zhao X, Sarruf DA, Izgur V, Maravilla KR, Nguyen HT, Fischer JD, Matsen ME, Wisse BE, Morton GJ, Horvath TL, Baskin DG, Tschöp MH, Schwartz MW 2011 Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 10.1172/ JCI59660 133.
133. 2011 Economic Research Service. U.S. Department of Agriculture. http://www.ers.usda.gov/data/foodconsumption/FoodAvailDoc.htm